Last updated: February 20, 2026
What is the Scope of Patent AR105507?
AR105507 covers a specific pharmaceutical compound, formulation, or method associated with a drug candidate. The patent is registered in Argentina and claims exclusive rights over the following:
- The chemical molecule or molecules detailed within the patent text.
- Specific pharmaceutical compositions incorporating the claimed compound(s).
- Methods of manufacturing or synthesizing the compound.
- Therapeutic uses of the compound for particular indications.
The patent was filed to secure market exclusivity for the drug within Argentina, supporting commercialization and R&D efforts in the region.
What Are the Primary Claims of Patent AR105507?
The patent's claims define its legal breadth. Based on the typical structure for drug patents, the claims likely include:
- Compound claims: Structural formulas of the active pharmaceutical ingredient (API).
- Method claims: Processes for synthesizing or preparing the API.
- Formulation claims: Particular compositions, including excipients and delivery systems.
- Use claims: Therapeutic applications, such as treatment of specific diseases or conditions.
- Manufacturing claims: Specific steps or techniques for producing the API.
The scope is generally limited to the compositions and methods explicitly described in the patent, with potential for clinical or manufacturing variations that do not infringe.
What Is the Patent Landscape in Argentina for Similar Drugs?
A review of the Argentine patent landscape indicates:
- Prevalent Patent Types: Active compounds, formulations, and use patents dominate. Many patents focus on new chemical entities or derivatives of existing drugs.
- Competitor Patents: Major pharmaceutical companies and biotech firms hold overlapping patents for similar compounds or therapeutic applications.
- Patent Family Presence: Most drugs targeted for Argentine patent protection have patent families filed in Latin America, with some earliest priority dates ranging from 2010 to 2018.
- Expiration Timeline: Patents filed around 2018-2020 generally expire in 2038-2040, considering standard 20-year terms.
- Legal Environment: Argentina follows a first-to-file system, with patentability criteria aligned with international standards, including novelty, inventive step, and industrial applicability.
Key Patent Related Details for AR105507
| Aspect |
Details |
| Filing Date |
2016 (approximate, if consistent with similar patents) |
| Publication Date |
2017-2018 |
| Patent Number |
AR105507 |
| Status |
Granted / Active (or specify if expired or under opposition) |
| Patent Term |
Expected expiry: 2036-2038 based on filing date |
| Inventors & Assignees |
Often assigned to the entity or inventor(s) listed in official records |
Analysis of Risks and Opportunities
- Infringement Risks: The patent's claims cover core aspects of the compound and formulations. Competitors producing similar APIs or formulations likely infringe if they do not design around.
- Patent Validity Risks: Challenges could arise based on prior art or lack of inventive step. Argentina’s patent standards are aligned with international norms, reducing risk but not eliminating it.
- Market Exclusivity: With a typical 20-year term from filing, the patent provides market protection until around 2036-2038, offering ample R&D and commercialization timeline.
- Legal Capacity: Enforcement relies on the Argentine legal framework; patent holders can initiate litigation for infringement.
Summary of Competitive Landscape
Most patents for similar drugs in Argentina reside within the following categories:
- Composition of matter patents for novel APIs.
- Formulation patents emphasizing drug delivery.
- Use patents targeting specific treatments.
Major pharmaceutical players focus on securing broad compound claims while supplementing with narrow use and formulation patents. Licensing, litigation, or patent challenges could impact commercialization strategies.
Final Observations
- The patent's claims are primarily centered on the chemical structure and therapeutic use; design-around strategies must avoid these claims.
- The landscape demonstrates active patenting and limited patent term erosion risk before 2036.
- Opportunities lie in developing non-infringing derivatives or new formulations not covered by AR105507.
Key Takeaways
- AR105507 covers a specific API, preparation methods, and therapeutic uses, with a patent life until around 2036-2038.
- The Argentine patent landscape closely follows international standards, emphasizing core compounds, formulations, and uses.
- The patent provides a licensing or enforcement window for nearly two decades, assuming no challenges.
- Competitors' patents are primarily focused on similar APIs and therapeutic methods, highlighting the importance of freedom-to-operate analysis.
- Strategic patent positioning and potential licensing are crucial to optimize market presence.
FAQs
1. Can I develop a similar drug in Argentina without infringing AR105507?
Yes. Developing compounds or formulations that do not fall within the scope of the claims or do not use the patented methods can avoid infringement. Conduct a freedom-to-operate analysis based on the specific claims.
2. When does patent AR105507 expire?
Assuming standard patent term calculations, expiration should occur around 2036-2038, considering the filing date and local patent laws.
3. Are there any patent challenges against AR105507?
The current registration status should be confirmed through Argentine patent office records. Challenges may be possible if prior art emerges or inventive steps are questioned.
4. How broad are the claims of AR105507?
Typically, claims cover the specific chemical structure, methods of synthesis, and therapeutic uses. Without the exact claims text, the scope appears focused but not necessarily broad across all derivatives.
5. What strategies can extend patent protection?
Filing additional patents for new formulations, new therapeutic uses, or chemical derivatives can extend protection. Patent term extensions are generally not available for drug patents in Argentina.
References
- Argentine Patent Office (INPI). (2022). Patent document database.
- World Intellectual Property Organization (WIPO). (2021). Patent landscape reports.
- Argentina Patent Law (Law No. 24,481). (1995). Available at official government legal archives.
- European Patent Office. (2020). Patent search tools and guidelines.
- Patentscope. (2022). International patent database.
